These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22350031)

  • 21. Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy.
    Kloosterman M; Rienstra M; Mulder BA; Van Gelder IC; Maass AH
    Europace; 2016 Aug; 18(8):1211-9. PubMed ID: 26718536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDD pacemaker for severe heart failure-alternate to CRT.
    Krishnamani NC
    Indian Heart J; 2017; 69(3):345-348. PubMed ID: 28648429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small left atrium and mild mitral regurgitation predict super-response to cardiac resynchronization therapy.
    Stefan L; Sedláček K; Černá D; Krýže L; Vančura V; Marek T; Kautzner J
    Europace; 2012 Nov; 14(11):1608-14. PubMed ID: 22490374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote past left ventricular function before chronic right ventricular pacing predicts responses to cardiac resynchronization therapy upgrade.
    Chang PC; Wo HT; Chen TH; Wu D; Lin FC; Wang CC
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):454-63. PubMed ID: 24251726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy.
    Miranda RI; Nault M; Johri A; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):927-32. PubMed ID: 22962420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction.
    Hai OY; Mentz RJ; Zannad F; Gasparini M; De Ferrari GM; Daubert JC; Holzmeister J; Lam CS; Pochet T; Vincent A; Linde C
    Eur J Heart Fail; 2015 Feb; 17(2):135-43. PubMed ID: 25469668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of the CRT-SCORE for Shared Decision Making in Cardiac Resynchronization Therapy in Patients With a Left Ventricular Ejection Fraction of ≤35.
    Höke U; Mertens B; Khidir MJH; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 Dec; 120(11):2008-2016. PubMed ID: 29031415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer Echocardiographic Techniques in Cardiac Resynchronization Therapy.
    Gorcsan J; Tayal B
    Card Electrophysiol Clin; 2015 Dec; 7(4):609-18. PubMed ID: 26596806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Super-responders" and "hypo-responders": neglecting the obvious question?
    Lim S
    J Am Coll Cardiol; 2012 Nov; 60(21):2258; author reply 2258-9. PubMed ID: 23153851
    [No Abstract]   [Full Text] [Related]  

  • 33. Absence of left ventricular apical rocking and atrial-ventricular dyssynchrony predicts non-response to cardiac resynchronization therapy.
    Tournoux F; Singh JP; Chan RC; Chen-Tournoux A; McCarty D; Manzke R; Ruskin JN; Semigran M; Heist EK; Moore S; Picard MH; Weyman AE
    Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):86-94. PubMed ID: 21921079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor.
    Ståhlberg M; Kessels R; Linde C; Braunschweig F
    Europace; 2011 Feb; 13(2):237-43. PubMed ID: 20952424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study.
    Gasparini M; Muto C; Iacopino S; Zanon F; Dicandia C; Distefano G; Favale S; Peraldo Neja C; Bragato R; Davinelli M; Mangoni L; Denaro A
    Am Heart J; 2012 Mar; 163(3):422-9. PubMed ID: 22424013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular endocardial pacing via the interventricular septum for cardiac resynchronization therapy: first report.
    Gamble JH; Bashir Y; Rajappan K; Betts TR
    Heart Rhythm; 2013 Dec; 10(12):1812-4. PubMed ID: 23891954
    [No Abstract]   [Full Text] [Related]  

  • 37. "Real world" experience in Cardiac Resynchronization Therapy at a Swiss Tertiary Care Center.
    Winnik S; Elsener C; Seifert B; Starck C; Straub A; Saguner AM; Breitenstein A; Krasniqi N; Wilhelm MJ; Haegeli L; Duru F; Benussi S; Maisano F; Lüscher TF; Holzmeister J; Huerlimann D; Ruschitzka F; Steffel J
    Swiss Med Wkly; 2017; 147():w14425. PubMed ID: 28421570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional propagation imaging of left ventricular activation by speckle-tracking echocardiography to predict responses to cardiac resynchronization therapy.
    Seo Y; Ishizu T; Kawamura R; Yamamoto M; Kuroki K; Igarashi M; Sekiguchi Y; Nogami A; Aonuma K
    J Am Soc Echocardiogr; 2015 May; 28(5):606-14. PubMed ID: 25797706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to cardiac resynchronization therapy as assessed by time-based speckle tracking imaging.
    Ghani A; Delnoy PP; Adiyaman A; Ottervanger JP; Ramdat Misier AR; Smit JJ; Elvan A
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):455-64. PubMed ID: 25684239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.